Ingunn Dybedal

4.2k total citations
39 papers, 1.9k citations indexed

About

Ingunn Dybedal is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Ingunn Dybedal has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 14 papers in Genetics and 11 papers in Immunology. Recurrent topics in Ingunn Dybedal's work include Acute Myeloid Leukemia Research (17 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Hemoglobinopathies and Related Disorders (7 papers). Ingunn Dybedal is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Hemoglobinopathies and Related Disorders (7 papers). Ingunn Dybedal collaborates with scholars based in Norway, Sweden and Denmark. Ingunn Dybedal's co-authors include Sten Eirik W. Jacobsen, Martin Jädersten, Scott Montgomery, David Bryder, Eva Hellström-Lindberg, Gunnar Grimfors, Anna Porwit‐MacDonald, Olle Linder, Jan Samuelsson and Gunnar Öberg and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ingunn Dybedal

37 papers receiving 1.8k citations

Peers

Ingunn Dybedal
Ingunn Dybedal
Citations per year, relative to Ingunn Dybedal Ingunn Dybedal (= 1×) peers Friedrich Wimazal

Countries citing papers authored by Ingunn Dybedal

Since Specialization
Citations

This map shows the geographic impact of Ingunn Dybedal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingunn Dybedal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingunn Dybedal more than expected).

Fields of papers citing papers by Ingunn Dybedal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingunn Dybedal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingunn Dybedal. The network helps show where Ingunn Dybedal may publish in the future.

Co-authorship network of co-authors of Ingunn Dybedal

This figure shows the co-authorship network connecting the top 25 collaborators of Ingunn Dybedal. A scholar is included among the top collaborators of Ingunn Dybedal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingunn Dybedal. Ingunn Dybedal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dybedal, Ingunn, Nina Iversen, Anne Flem Jacobsen, et al.. (2025). Hereditary antithrombin deficiency and venous thrombosis in pregnancy–results of a retrospective multicenter study. Journal of Thrombosis and Haemostasis. 23(9). 2807–2818.
2.
Mitsuiki, Noriko, Florian Emmerich, Virginia Patiño, et al.. (2025). The effect of HLA genotype on disease onset and severity in CTLA-4 insufficiency. Frontiers in Immunology. 15. 1447995–1447995. 1 indexed citations
3.
Nilsson, Lars, Magnus Tobiasson, Martin Jädersten, et al.. (2025). Influence of Cytogenetics on the Outcome of Patients With High‐Risk Myelodysplastic Syndrome Including Deletion 5q Treated With Azacitidine With or Without Lenalidomide. Genes Chromosomes and Cancer. 64(2). e70029–e70029. 1 indexed citations
4.
Baliakas, Panagiotis, Bianca Tesi, Jörg Cammenga, et al.. (2024). How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms. HemaSphere. 8(8). e145–e145. 3 indexed citations
5.
Uhlmann, Annette, Gabriele Ihorst, Sigune Goldacker, et al.. (2022). The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial. Contemporary Clinical Trials Communications. 30. 101008–101008. 14 indexed citations
6.
Remberger, Mats, Jonas Mattsson, T Egeland, et al.. (2020). The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors. SHILAP Revista de lepidopterología. 2(2). 74–74. 13 indexed citations
7.
Baliakas, Panagiotis, Bianca Tesi, Ulla Wartiovaara‐Kautto, et al.. (2019). Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up. HemaSphere. 3(6). e321–e321. 53 indexed citations
8.
Tran, Hoa, Ulla Randen, Signe Spetalen, et al.. (2018). Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report. Journal of Medical Case Reports. 12(1). 105–105. 2 indexed citations
9.
Ljungström, Viktor, Jakob Werner Hansen, Astrid Olsnes Kittang, et al.. (2016). Molecular Profiling In A Population Based Cohort Of Nordic Myelodysplastic Syndrome Patients. Haematologica. 101. 72–72. 1 indexed citations
10.
Tekpli, Xavier, Alfonso Urbanucci, Cathrine Broberg Vågbø, et al.. (2016). Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells. Epigenetics & Chromatin. 9(1). 21–21. 18 indexed citations
11.
Brinch, Lorentz, Geir E. Tjønnfjord, Tobias Gedde‐Dahl, et al.. (2014). Allogen stamcelletransplantasjon hos voksne 1985 – 2012. Tidsskrift for Den norske legeforening. 134(16). 1569–1575. 3 indexed citations
13.
Fløisand, Yngvar, Lorentz Brinch, Tobias Gedde‐Dahl, et al.. (2012). Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 47(12). 1552–1557. 6 indexed citations
14.
Möllgård, Lars, Leonie Saft, Marianne Bach Treppendahl, et al.. (2011). Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities. Haematologica. 96(7). 963–971. 43 indexed citations
15.
Mustjoki, Satu, Marja Ekblom, T. Petteri Arstila, et al.. (2009). Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy. Leukemia. 23(8). 1398–1405. 229 indexed citations
16.
Fløisand, Yngvar, Ingunn Dybedal, Tobias Gedde‐Dahl, et al.. (2008). Allogen stamcelletransplantasjon hos voksne med akutt lymfoblastisk leukemi. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
17.
Jädersten, Martin, Scott Montgomery, Ingunn Dybedal, Anna Porwit‐MacDonald, & Eva Hellström-Lindberg. (2005). Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF. Blood. 106(3). 803–811. 143 indexed citations
18.
Yang, Liping, Ingunn Dybedal, David Bryder, et al.. (2005). IFN-γ Negatively Modulates Self-Renewal of Repopulating Human Hemopoietic Stem Cells. The Journal of Immunology. 174(2). 752–757. 83 indexed citations
19.
Dybedal, Ingunn, Stephen Larsen, & Sten Eirik W. Jacobsen. (1995). IL-12 directly enhances in vitro murine erythropoiesis in combination with IL-4 and stem cell factor.. The Journal of Immunology. 154(10). 4950–4955. 44 indexed citations
20.
Hellström-Lindberg, Eva, Gunnar Birgegård, Magnus Carlsson, et al.. (1993). A Combination of Granulocvte Colonv-Stimulating Factor and Erythiopoietin may Synergistically Improve the Anaemia in Patients with Myelodysplastic Syndromes. Leukemia & lymphoma. 11(3-4). 221–228. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026